Navigation Links
Savient Pharmaceuticals Marketing Authorization Application for KRYSTEXXA® Accepted for Review by European Medicines Agency
Date:5/26/2011

of our MAA filing before the EMA and market demand within the European Union are forward-looking statements. These forward-looking statements involve substantial risks and uncertainties and are based on our assessment and interpretation of the currently available data and information, current expectations, assumptions, estimates and projections about our business and the biopharmaceutical and specialty pharmaceutical industries in which we operate. Important factors that may affect our ability to achieve the matters addressed in these forward-looking statements include, but are not limited to, our ability to commercialize KRYSTEXXA; our ability to retain the personnel whom we have hired and to hire the remaining personnel necessary to complete the build out of our commercial team; our reliance on third parties to manufacture KRYSTEXXA; the risk that the market for KRYSTEXXA is smaller than we have anticipated; competition from existing therapies and therapies that are currently under development, including therapies that are significantly less expensive than KRYSTEXXA; our ability to gain market acceptance for KRYSTEXXA among physicians, patients, health care payors and others in the medical community; whether we are able to obtain financing, if needed; economic, political and other risks associated with foreign operations; risks of maintaining protection for our intellectual property; risks of an adverse determination in intellectual property litigation; and risks associated with stringent government regulation of the biopharmaceutical industry and other important factors set forth more fully in our reports filed with the Securities and Exchange Commission, to which investors are referred for further information. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements, which speak only as of the date of publication of this press release.
'/>"/>
SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
7. Savient Provides Update on KRYSTEXXA(TM) BLA Resubmission Activities
8. Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
9. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
10. Savient Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
11. Savient Pharmaceuticals To Hold First Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... Allowing more basic emergency medical service (EMS) staff to ... opioids, according to a Centers for Disease Control and ... Medical Service Providers and the Burden of Drug Overdose ... of Public Health . In 2013, more ... involved prescription opioids, and more than 8,000 ...
(Date:4/24/2015)... 24, 2015 In today,s ever-changing and ... around the world to access diverse skill sets, ... there are many areas to misstep in the ... best practices are necessary and beneficial in order ... According to research by benchmarking firm, Best Practices, ...
(Date:4/24/2015)... , Apr. 24, 2015 Research and ... announced the addition of the "Lab ... tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station) & End User ... Global Forecast to 2020" report to ... accessories market is expected to reach $504.7 ...
Breaking Medicine Technology:Expanding Naloxone use could reduce drug overdose deaths and save lives 2Expanding Naloxone use could reduce drug overdose deaths and save lives 3Work Around the Clock: Building Effective Global Capabilities 2Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 2Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 3
... SILVER SPRING, Md., May 13, 2011 The U.S. Food ... represented as "ExtenZe," which is the name of an authentic ... similar to the actual product, but contains hidden ingredients that ... the following lot numbers on the packages: ...
... 13, 2011 Amnis Corporation, a manufacturer of advanced ... new FlowSight imaging flow cytometer. The FlowSight ... unrivalled fluorescence sensitivity and the breakthrough ability to produce ... upgraded in the factory or the field with up ...
Cached Medicine Technology:FDA Warns About Counterfeit ExtenZe Dietary Supplements 2
(Date:4/25/2015)... The URO CENTER of NEW YORK is ... by the New York Academy of Medicine to receive the ... field of Urology. , Dr. Ferdinand Valentine, born in 1851, ... He was a man of rare and attractive personality ... Not only did he devote his life to his profession ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 Bird B Gone, ... residential applications now offers a complete line of bird control ... poultry farms. , New Flu Strains Threaten Pacific, Central and ... USDA post , a number of highly pathogenic avian ... The disease is often spread when wild birds enter poultry ...
(Date:4/24/2015)... Foothill Ranch, California (PRWEB) April 24, 2015 ... that has a wide range of capabilities and services ... etc. , Ryadon's Quantity Discount Program will be ... ) as follows: , Order 4-19: Receive 10% discount ... Can Benefit by Using the Drawer Slides Products, ...
(Date:4/24/2015)... The 1975 have had an ... the globe to theaters, festivals and TV performances. Now that ... with their label, Dirty Hit Records, to provide clean drinking ... newly launched Cadence & Cause website, this four-piece ... vinyl and a signed photo card. Entries from this ...
(Date:4/24/2015)... Carinsurancequotesinfo.com has released a new blog post ... qualify for auto insurance as a single ... insurance online, without having to follow a special process. ... can reduce their auto insurance expenses. The tips are ... , Clients can now visit an insurance brokerage ...
Breaking Medicine News(10 mins):Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 2Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 4Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 3Health News:Internationally Recognized British Indie Rock Outfit The 1975 Partner with Cadence & Cause to Provide Clean Drinking Water to Those in Need 2Health News:Auto Insurance Discounts for Single Parents - How to Qualify for Low Rates 2
... LAUDERDALE, Fla., Sept. 1 In November, the world,s most ... (NAC) in Florida to cover everything from cutting-edge research to ... , The speaker lineup is set to ... Dr. Russell Blaylock, Dr. Jerry Kartzinel, writer David Kirby, and ...
... , , BURBANK, ... health expert, Dra. Aliza Lifshitz, announced a partnership today to reach ... Looney Tunes as ambassadors for the program. The partnership will ... to best care for and nurture their babies. Launching in ...
... , , Republicans Losing Confidence ... Sept. 1 According to a 3-year time series analysis of the ... and July 2009), Democrats have increased their ratings on top Latino priority ... , , "This data shows that Congressional ...
... , LOS ANGELES, Sept. 1 Azteca America television ... California gubernatorial candidate Gavin Newsom on the Sept. 1 broadcast of ... Armando Guzman. , , As a self-styled ... plan for universal healthcare and San Francisco is probably the highest ...
... finds , TUESDAY, Sept. 1 (HealthDay News) -- A ... nerve connections failed to improve upon regular laparoscopic surgery ... nerve-disruption procedure "did not alleviate any type of pain…or ... or absence of mild endometriosis," according to the authors ...
... procedure can be done up to 21 hours later with ... News) -- Many people who arrive at hospital emergency rooms ... for artery-opening angioplasty, even if an electrocardiogram (EKG) shows evidence ... There was no significant difference in key measures of heart ...
Cached Medicine News:Health News:Kartzinel, Herbert, Blaylock, Mukhopadhyay and Other Autism Experts Join Keynote Speaker Andrew Wakefield at The 2009 National Autism Conference 2Health News:Video: Renowned Health Expert Dra. Aliza Teams Up With Baby Looney Tunes To Promote Healthy, Happy Babies 2Health News:Video: Renowned Health Expert Dra. Aliza Teams Up With Baby Looney Tunes To Promote Healthy, Happy Babies 3Health News:Video: Renowned Health Expert Dra. Aliza Teams Up With Baby Looney Tunes To Promote Healthy, Happy Babies 4Health News:Congressional Democrats Achieve Credibility With Latino Voters 2Health News:San Francisco Mayor Gavin Newsom Talks About Immigration and Drugs on Azteca America's 'Issues: Caras y Voces' 2Health News:Two Treatments Equally Effective for Chronic Pelvic Pain 2Health News:Sometimes Angioplasty Can Wait 2
... proven and reliable system. Varian accelerators ... patient treatment, fastest beam-on times to ... than 500 milliseconds, pulse-to-pulse beam control ... greatest number of multileaf collimator (MLC) ...
The MULTI-LINK ZETA Coronary Stent System utilizes the same clinically proven implant as the MULTI-LINK PENTA Coronary Stent System, maintaining the benefits of a 17.5% binary restenosis rate....
Take Performance to a Higher Level....
A fusion of first class deliverability, acute angiographic results and excellent versatility....
Medicine Products: